Literature DB >> 19296423

[Prostate cancer centres / prostate centres--certified by DKG or DVPZ].

C Arsov1, P Albers.   

Abstract

In Germany, ambitious efforts for the implementation of well-defined quality standards in the diagnosis of and therapy for prostate cancer have resulted in the creation of certified centres over the past years. This development is in analogy to that of certified breast and intestinal centres. Concerning the prostate, there are two different models for the certification of centres. The model of the Dachverband der Prostatazentren e. V. (DVPZ) includes the most common kinds of dis-eases of the prostate, namely BPH, prostate cancer and prostatitis. On the other hand prostate cancer centres are certified by the Deutsche Krebsgesellschaft (DKG). Among German urologists there is a controversial discussion concerning this process. The present paper gives a review of the two models and discusses the chances as well as the risks which come along with certified centres.

Entities:  

Mesh:

Year:  2009        PMID: 19296423     DOI: 10.1055/s-0028-1098851

Source DB:  PubMed          Journal:  Aktuelle Urol        ISSN: 0001-7868            Impact factor:   0.658


  3 in total

1.  [Introduction of interdisciplinary prostate cancer centers based on the recommendations of the German Cancer Society. A cost-benefit analysis 3 years after accreditation].

Authors:  S Weikert; D Baumunk; C Stephan; H Cash; K Jahnke; U Steiner; P Werthemann; C Kempkensteffen; A Magheli; S Hinz; A Jagota; U Reichelt; J Busch; C Klopf; K Miller; M Schostak
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

2.  [Certified prostate cancer centers of the German Cancer Society : Current status 2 years after certification and future developments].

Authors:  J A Steffens; O Ting; S Schmidt; P Albers
Journal:  Urologe A       Date:  2010-08       Impact factor: 0.639

3.  [Documentation of the Governing Body of Prostate Centers (DVPZ)].

Authors:  B Brehmer; R Berges; T Ebert; M Goepel; A Heidenreich
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.